Design, synthesis and antiproliferative activity of oxadiazole derivatives as potent glycogen synthase kinase-3/histone deacetylase 6 dual inhibitors. [PDF]
Ye C +7 more
europepmc +1 more source
RETRACTION: Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer's Disease. [PDF]
Applications BCA.
europepmc +1 more source
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma. [PDF]
Hanna GJ +11 more
europepmc +1 more source
Correction to "Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients". [PDF]
Maurya N +6 more
europepmc +1 more source
Glycogen synthase kinase 3β: a key player in progressive chronic kidney disease. [PDF]
Zhang M, Tatar M, Gong R.
europepmc +1 more source
Lithium-Charged Gold Nanoparticles: A New Powerful Tool for Lithium Delivery and Modulation of Glycogen Synthase Kinase 3 Activity. [PDF]
Buonerba A +20 more
europepmc +1 more source
Computational identification of phytochemicals as glycogen synthase kinase 3 beta (GSK3β) inhibitors for therapeutic applications in chronic diseases. [PDF]
Azmal M +4 more
europepmc +1 more source
Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2. [PDF]
Chen J +10 more
europepmc +1 more source

